Recipharm will serialize customers' drugs for free until US and EU rules come into force
Recipharm has announced it will serialize customers’ products for free until legislation comes into force in key markets.
Recipharm has announced it will serialize customers’ products for free until legislation comes into force in key markets.
Catalent Pharma Solutions has released a new clinical supply labeling tool in response to a "work-around" which could put patients' safety at risk.
Combination therapies and collaboration will be key in curing cancer, according to Pfizer which has seen 'astounding progress' in its immuno-oncology partnership with Merck KGaA.
German discovery services firm Evotec has had its contract with Genentech extended for a second time
Charles River Laboratories is conducting new studies using animal models to give insight into therapeutic strategies where pharma companies expect to see the most success.